Try our beta test site
3 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) | abexinostat
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
Conditions: Lymphoma;   Hodgkin Disease;   Lymphoma, Non-Hodgkin
Intervention: Drug: PCI-24781
2 Completed A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
Conditions: Lymphoma;   Non-Hodgkin's Lymphoma;   Hodgkin Disease;   Multiple Myeloma;   Leukemia;   Lymphocytic
Intervention: Drug: PCI-24781
3 Completed Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
Conditions: Neoplasms by Site;   Lymphoma, Non-hodgkin;   Hodgkin Disease;   Multiple Myeloma;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: PCI-24781

Study has passed its completion date and status has not been verified in more than two years.